Hepatitis C virus molecular clones : from cDNA to infectious virus particles in cell cultureBARTENSCHLAGER, Ralf.Current opinion in microbiology. 2006, Vol 9, Num 4, pp 416-422, issn 1369-5274, 7 p.Article

Intracellular Pathogens and PersistenceBARTENSCHLAGER, Ralf.FEMS microbiology reviews. 2012, Vol 36, Num 3, issn 0168-6445, 248 p.Serial Issue

The hepatitis C virus replicon system : From basic research to clinical applicationBARTENSCHLAGER, Ralf.Journal of hepatology. 2005, Vol 43, Num 2, pp 210-216, issn 0168-8278, 7 p.Article

Failure of innate and adaptive immune responses in controlling hepatitis C virus infectionTHIMME, Robert; BINDER, Marco; BARTENSCHLAGER, Ralf et al.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 663-683, issn 0168-6445, 21 p.Article

Role of RNA Structures in Genome Terminal Sequences of the Hepatitis C Virus for Replication and AssemblyFRIEBE, Peter; BARTENSCHLAGER, Ralf.Journal of virology. 2009, Vol 83, Num 22, pp 11989-11995, issn 0022-538X, 7 p.Article

Novel cell culture systems for the hepatitis C virusBARTENSCHLAGER, Ralf; LOHMANN, Volker.Antiviral research. 2001, Vol 52, Num 1, pp 1-17, issn 0166-3542Article

T cell response and persistence of the microsporidiaGHOSH, Kaya; WEISS, Louis M.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 748-760, issn 0168-6445, 13 p.Article

Mutational analysis of hepatitis C virus nonstructural protein 5A : Potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domainAPPEL, Nicole; PIETSCHMANN, Thomas; BARTENSCHLAGER, Ralf et al.Journal of virology. 2005, Vol 79, Num 5, pp 3187-3194, issn 0022-538X, 8 p.Article

Persistence of Bartonella spp. stealth pathogens: from subclinical infections to vasoproliferative tumor formationPULLIAINEN, Arto T; DEHIO, Christoph.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 563-599, issn 0168-6445, 37 p.Article

Efficient rescue of Hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5AAPPEL, Nicole; HERIAN, Ulrike; BARTENSCHLAGER, Ralf et al.Journal of virology. 2005, Vol 79, Num 2, pp 896-909, issn 0022-538X, 14 p.Article

Quantitative analysis of the hepatitis C virus replication complexQUINKERT, Doris; BARTENSCHLAGER, Ralf; LOHMANN, Volker et al.Journal of virology. 2005, Vol 79, Num 21, pp 13594-13605, issn 0022-538X, 12 p.Article

Mycobacterium tuberculosis: success through dormancyGENGENBACHER, Martin; KAUFMANN, Stefan H. E.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 514-532, issn 0168-6445, 19 p.Article

Experimental models to study the immunobiology of hepatitis C virusJO, Juandy; LOHMANN, Volker; BARTENSCHLAGER, Ralf et al.Journal of general virology. 2011, Vol 92, pp 477-493, issn 0022-1317, 17 p., 3Article

Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic VirusesHAASNOOT, Joost; BERKHOUT, Ben.Handbook of experimental pharmacology. 2009, Vol 189, pp 243-263, issn 0171-2004, 21 p.Article

Salmonella's long-term relationship with its hostRUBY, Thomas; MCLAUGHLIN, Laura; GOPINATH, Smita et al.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 600-615, issn 0168-6445, 16 p.Article

The molecular basis of herpes simplex virus latencyNICOLL, Michael P; PROENCA, Joao T; EFSTATHIOU, Stacey et al.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 684-705, issn 0168-6445, 22 p.Article

Antiviral Agents Acting as DNA or RNA Chain TerminatorsDE CLERCQ, E; NEYTS, J.Handbook of experimental pharmacology. 2009, Vol 189, pp 53-84, issn 0171-2004, 32 p.Article

Socio-Economic Impact of Antiviral InterventionFLESSA, S; MARSCHALL, P.Handbook of experimental pharmacology. 2009, Vol 189, pp 347-374, issn 0171-2004, 28 p.Article

HIV latency: experimental systems and molecular modelsHAKRE, Shweta; CHAVEZ, Leonard; SHIRAKAWA, Kotaro et al.FEMS microbiology reviews. 2012, Vol 36, Num 3, pp 706-716, issn 0168-6445, 11 p.Article

Reconstructing signaling pathways from RNAi data using probabilistic Boolean threshold networksKADERALI, Lars; DAZERT, Eva; ZEUGE, Ulf et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 17, pp 2229-2235, issn 1367-4803, 7 p.Article

Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-cultureSTEUER, Christian; GEGE, Christian; FISCHL, Wolfgang et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 13, pp 4067-4074, issn 0968-0896, 8 p.Article

Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variantKAUL, Artur; WOERZ, Ilka; MEULEMAN, Philip et al.Journal of virology. 2007, Vol 81, Num 23, pp 13168-13179, issn 0022-538X, 12 p.Article

Viral Protease InhibitorsANDERSON, Jeffrey; SCHIFFER, Celia; LEE, Sook-Kyung et al.Handbook of experimental pharmacology. 2009, Vol 189, pp 85-110, issn 0171-2004, 26 p.Article

Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2'-C-methylcytidine, the active component of valopicitabineCOELMONT, Lotte; PAESHUYSE, Jan; WINDISCH, Marc P et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 10, pp 3444-3446, issn 0066-4804, 3 p.Article

Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus InfectionHOFMANN, Wolf Peter; SORIANO, Vincent; ZEUZEM, Stefan et al.Handbook of experimental pharmacology. 2009, Vol 189, pp 321-346, issn 0171-2004, 26 p.Article